Ruijin Hospital has released a white paper on the construction of a digital and intelligent pathology department, with AI assisted pathology diagnosis significantly accelerating intelligence | pathology | AI assisted
Pathology is the "gold standard" for disease diagnosis. In the wave of digital transformation in healthcare, the pathology department of hospitals has ushered in new development opportunities. At the recent Sino French International Forum on Translational Medicine and Precision Diagnosis and Treatment, the Digital Intelligent Pathology Development Sub Forum, the White Paper on the Construction of Digital Intelligent Pathology, edited by the Pathology Department of Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine and participated by Shanghai Shangtang Intelligent Technology Co., Ltd., was released, providing reference experience for the digital and intelligent transformation and upgrading of hospital pathology departments.
The White Paper points out that the construction of digital intelligent pathology mainly includes three construction modules: informatization, digitization, and intelligence, which is the future development trend of pathology. Among them, the information module is based on an information management system, which digitally upgrades the workflow of the pathology department; The digital module solves the problems of lagging and mosaic in accessing pathological sections, as well as the high storage cost of sections; The intelligent module is based on the organic integration of AI and pathology workflow, achieving efficient AI assisted diagnosis.
By analyzing the construction cases of digital and intelligent pathology departments in more than ten domestic hospitals, the White Paper gathers the accumulated experience of various parties in the construction of digital and intelligent pathology departments, and proposes clear and highly operable suggestions for the construction of digital and intelligent pathology departments. The White Paper provides an outlook on the future development direction of digital pathology, pointing out the important value of establishing scientific and unified industry standards and norms.
In the process of writing the White Paper, Shangtang Technology participated in the writing of how AI technology empowers pathological clinical work and pathological research related content. In recent years, this company has carried out various research and development work on pathological AI assisted diagnosis models and algorithms, helping Ruijin Hospital achieve assisted pathological diagnosis using the "medical digital brain".
At present, the application of pathological AI assisted diagnosis has covered multiple scenarios such as digestive tract biopsy pathological examination and TCT cervical cytology screening. Among them, in the initial diagnosis of digestive tract biopsy and cervical cytology, the AI algorithm has a negative rejection rate of over 80% and extremely high sensitivity, which can assist doctors in quickly screening a large number of negative cases, allowing doctors to focus their main energy on the diagnosis of suspicious lesion cells and tissue areas, significantly improving the speed of film reading and solving the problem of pathological doctors' workload overload.
With the help of Shangtang's self-developed digital film reading platform, Ruijin Hospital has created a full stack intelligent pathological workflow, allowing AI examination results confirmed by initial doctors to be automatically imported into diagnostic reports. The pathological diagnosis report, which originally required 3-5 days, can now be delivered to patients in just 2 days, optimizing the patient's medical experience.
For scientific research, Shangtang Technology utilizes AI technology to integrate and analyze fragmented pathological information, and establishes a digital pathological database. Based on this database, the artificial intelligence digital pathology research annotation platform and the artificial intelligence digital pathology self-learning platform constructed by Ruijin Hospital can significantly improve the efficiency of pathology research, create a multi disease AI research application system, and achieve a closed loop of digital intelligent pathology department construction.
In the future, the Pathology Department of Ruijin Hospital and Shangtang Technology will continue to cooperate to further develop an intelligent pathology platform based on the standards of "digitalization within the hospital, homogenization of multiple hospital areas, and remote medical consortium". At the same time, both parties hope to promote the "Ruijin Pathology Experience" to more hospitals, promote the digitalization, intelligent upgrading, and standardized development of pathology departments in China, and better serve patients.